CDK8 and neoplasm: Case 14 was notable in that analysis by IMPACT revealed no mutations in both the beta-catenin and RAS pathways, although the tumor harbored an amplification of CDK8, which has be shown to dysregulate the WNT/beta-catenin pathway [12].